# 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression

> **NCT02389712** · PHASE4 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 2 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Lamotrigine
- **DRUG:** Fluoxetine

## Key facts

- **NCT ID:** NCT02389712
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2018-05-23
- **Final completion:** 2018-05-23
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Difficulties with recruitment
- **Last updated:** 2019-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02389712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02389712, "16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02389712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*